HopeStage
Back to all studies
CompletedNCT00034229

Felbamate for depression in bipolarity that has not improved with treatment

About this title

Clinical Trial of Felbamate for Treatment-Resistant Bipolar Depression

Read the official source — NCT00034229
Medication studyUnited States
The study in practice

Understand this study

Listed locations
BethesdaSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateApril 2002
Recruitment status
Completed
Enrollment listed in the registry
52
Sponsor
National Institute of Mental Health (NIMH)
Sponsor type
Government agency
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
Not clearly listed
Official registry ID
NCT00034229
Official title
Show the full official title

A Double-Blind Randomized Placebo-Controlled Trial of Felbamate in Treatment Resistant Bipolar Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Bethesda

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute of Mental Health (NIMH), a government agency.

Did this study involve medication?

Yes. The study involved medication, including Felbamate.

Want to explore more studies?

Explore studies